# PANCREAZE

NDC: 62541-405
Generic name: PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
Labeler / Manufacturer: VIVUS LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20100412

FDA application: BLA022523

## Active ingredients

- PANCRELIPASE AMYLASE: 83900 [USP'U]/1
- PANCRELIPASE LIPASE: 21000 [USP'U]/1
- PANCRELIPASE PROTEASE: 54700 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62541-405"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62541-405
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8f5d2fe-728d-42af-99a6-83dddc6539c5